| tyyppi : |
Laboratorio |
|
| tutkimus Joukkueet : |
|
| Tekijät : |
|
| Otsikko : |
Isatuximab - SARCLISA 20mg/mL concentrate for solution for infusion - Summary of Product Characteristics - updated 16 August 2021 |
| Numero : |
Sanofi Genzyme 2021 |
|
| Todisteiden määrä : |
|
| fyysinen vakaus : |
|
| kemiallinen stabiilisuus : |
|
| Muut menetelmät : |
|
| commentairesvaleur : |
|
Luettelo yhdisteistä
 Isatuximab
|
 |
 |
 |
 |
? mg/ml |
15-25°C |
 |
| 8 |
 |
|
|
|
|
|
? mg/ml |
2-8°C |
|
| 48 |
|
|
|
|
|
 |
? mg/ml |
15-25°C |
|
| 8 |
|
|
|
|
|
|
? mg/ml |
2-8°C |
|
| 48 |
|
|
|
|
 |
|
? mg/ml |
15-25°C |
|
| 8 |
|
|
|
|
|
|
? mg/ml |
2-8°C |
|
| 48 |
|
|
|
|
|
|
? mg/ml |
15-25°C |
|
| 8 |
|
|
|
|
|
|
? mg/ml |
2-8°C |
|
| 48 |
|
|
|
|
 |
|
? mg/ml |
15-25°C |
|
| 8 |
|
|
|
|
|
|
? mg/ml |
2-8°C |
|
| 48 |
|
|
|
|
|
|
? mg/ml |
15-25°C |
|
| 8 |
|
|
|
|
|
|
? mg/ml |
2-8°C |
|
| 48 |
|
|
|
|
 |
|
? mg/ml |
15-25°C |
|
| 8 |
|
|
|
|
|
|
? mg/ml |
2-8°C |
|
| 48 |
|
|
|
|
|
|
? mg/ml |
15-25°C |
|
| 8 |
|
|
|
|
|
|
? mg/ml |
2-8°C |
|
| 48 |
|
|
|
|
 |
|
? mg/ml |
15-25°C |
|
| 8 |
|
|
|
|
|
|
? mg/ml |
2-8°C |
|
| 48 |
|
|
|
|
|
|
? mg/ml |
15-25°C |
|
| 8 |
|
|
|
|
|
|
? mg/ml |
2-8°C |
|
| 48 |
|
|
|
|
|
| |
+
|
|
|
|
|
| |
+
|
|
|
|
